International Business Machines Corporation (NYSE:IBM) has renewed efforts to sell IBM Watson Health, Inc. and looks to fetch more than $1 billion for the unit, Axios' Sarah Pringle reports, citing people familiar with the matter. IBM first explored a sale of the division in early 2021, with Morgan Stanley leading the process, and engaged BofA Securities in late 2021 to find a buyer for the unit. According to one source, bids were due on January 04, 2022, and IBM looks to select the winner by the end of January 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
181.6 USD | +0.06% | -0.38% | +11.02% |
Apr. 19 | S&P 500 Posts Third Consecutive Weekly Drop, Led by Tech, Consumer Discretionary Amid Mixed Earnings, Middle East Turmoil | MT |
Apr. 19 | Hyundai pauses ads on X over brand safety issues | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.02% | 166B | |
-9.70% | 199B | |
+0.86% | 166B | |
+4.44% | 99.95B | |
+6.17% | 76.71B | |
-8.53% | 70.07B | |
+10.70% | 68.36B | |
-26.91% | 48.57B | |
-1.27% | 47.01B | |
+6.01% | 36.56B |
- Stock Market
- Equities
- IBM Stock
- News IBM
- IBM Reportedly Renews Efforts to Sell Watson Health, Looks to Fetch over $1Billion